Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory
#MMPMID32761155
Greene DN
J Appl Lab Med
2020[Jul]; 5
(4
): 837-840
PMID32761155
show ga
In early March 2020 it became apparent that clinical laboratories would need to
quickly develop strategies for SARS-CoV-2/COVID-19 testing. For most, the initial
approach was to send out testing to a reference laboratory. As the pandemic has
progressed, the food and drug administration (FDA) has allowed for several
manufacturers to make testing reagents commercially available. Concurrently, the
demand for rapid accessibility of results persists, leading many laboratories to
evaluate options for ?in house? testing. This reflection highlights some of the
considerations when selecting the best method for your laboratory, with specific
examples highlighted from a medium volume laboratory?s experience.
free
free
free
